Clinical Trial Update: Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study. [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, double-blind randomized trial is evaluating lidocaine versus placebo for opioid-refractory cancer pain with a neuropathic component in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Cancer, Pain With Neuropathic Component | Phase 3 | Status: UNKNOWN